LTR Pharma Limited (ASX: LTP)

LTR Pharma Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	3.1	3.1	1.73	1.91	0.15
Cash & Short-Term Investments	3.1	3.1	1.73	1.91	0.15
Cash Growth	79.46%	79.46%	-9.56%	1205.48%	-
Other Receivables	0.27	0.27	0.06	0.04	-
Receivables	0.27	0.27	0.06	0.04	-
Total Current Assets	3.37	3.37	1.79	1.95	0.15
Property, Plant & Equipment	0	0	-	-	-
Other Long-Term Assets	-	-	-	-	0
Total Assets	3.37	3.37	2.09	2.25	0.42
Accounts Payable	0.24	0.24	0.01	0.47	0
Accrued Expenses	0.13	0.13	0.01	0.01	0
Short-Term Debt	-	-	-	-	0.36
Other Current Liabilities	0.06	0.06	-	-	0.1
Total Current Liabilities	0.43	0.43	0.02	0.48	0.46
Total Liabilities	0.43	0.43	0.02	0.48	0.46
Common Stock	10.74	10.74	4.53	2.79	-
Retained Earnings	-9.48	-9.48	-2.52	-1.07	-0.04
Comprehensive Income & Other	1.67	1.67	0.07	0.04	-
Shareholders' Equity	2.94	2.94	2.07	1.77	-0.04
Total Liabilities & Equity	3.37	3.37	2.09	2.25	0.42
Total Debt	-	-	-	-	0.36
Net Cash (Debt)	3.1	3.1	1.73	1.91	-0.21
Net Cash Growth	79.46%	79.46%	-9.56%	-	-
Net Cash Per Share	0.02	0.02	0.01	-	-
Filing Date Shares Outstanding	153.8	153.8	414.9	-	-
Total Common Shares Outstanding	139.42	139.42	414.9	-	-
Working Capital	2.94	2.94	1.77	1.48	-0.32
Book Value Per Share	0.02	0.02	0.00	-	-
Tangible Book Value	2.94	2.94	2.07	1.77	-0.04
Tangible Book Value Per Share	0.02	0.02	0.00	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.